Vitiligo
Pathophysiology
• Autoimmune destruction of melanocytes
• Associated with other autoimmune diseases:
o Autoimmune thyroid disease (Hashimoto’s, Graves’)
o Type 1 diabetes
o Pernicious anaemia
o Addison’s disease
Clinical features
• Depigmented macules and patches, well-defined, often symmetrical
• Common sites: periorificial areas (mouth, eyes), hands, extensor surfaces
Treatment
• Potent topical steroids
• Calcineurin inhibitors (tacrolimus) for facial lesions
• Phototherapy (narrowband UVB)
• Cosmetic camouflage
Post-inflammatory Hypo-/Hyperpigmentation
Causes
• After eczema, psoriasis, burns, trauma
• Common in darker skin types
Features
• Hyperpigmentation: excess melanin deposition in basal layer
• Hypopigmentation: temporary reduction in melanin or melanocyte function
Management
• Often resolves over time
• Sun protection to minimise contrast
Albinism
Pathophysiology
• Congenital absence or defect in melanin synthesis, usually tyrosinase deficiency
• Oculocutaneous types affect skin, hair, eyes
Clinical features
• Generalised hypopigmentation of skin and hair
• Ocular signs:
o Nystagmus
o Reduced visual acuity
o Photophobia
Complications
• Markedly increased risk of UV-induced skin cancers (BCC, SCC)
Melasma (Chloasma)
Pathophysiology
• Hypermelanosis triggered by:
o Hormonal changes (pregnancy, OCP use)
o UV exposure
Clinical features
• Symmetrical hyperpigmented macules, usually on cheeks, forehead, upper lip
Management
• Sun protection
• Topical depigmenting agents (hydroquinone, azelaic acid)
• Consider retinoids
Addison’s Disease
Pathophysiology
• Primary adrenal insufficiency → ↑ ACTH
• ACTH cross-reacts with melanocyte-stimulating hormone (MSH)
Clinical features
• Generalised hyperpigmentation, especially:
o Sun-exposed areas
o Pressure points (elbows, knees, knuckles)
o Buccal mucosa and palmar creases (classic exam clue)
Extra Revision Pearls
• Vitiligo + new hyperpigmentation → suspect Addison’s
• Melasma: exacerbated by sunlight and oestrogen
• Albinism: avoid excessive sun exposure; regular skin cancer surveillance
• Post-inflammatory pigment changes: especially common in Fitzpatrick skin types IV–VI